Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men
1 other identifier
interventional
24
1 country
1
Brief Summary
Diminished use of skeletal muscle, such as occurs with many chronic diseases (e.g., heart failure or cancer cachexia), denervation, bedrest, immobilization (e.g., limb casting or bracing), etc., is a common clinical condition affecting untold millions of individuals each year. Such disuse leads to a rapid decline in muscle fiber area and hence whole muscle size, contributing to a decrease in strength, speed, and power as well as alterations in energy metabolism. Collectively, these changes lead to reduced physical function and contribute to the seriousness of any disease, illness (e.g., pneumonia), surgery (e.g., joint replacement), or injury (e.g., broken bone) accompanied by decreased muscular activity. Currently, there are no effective pharmacological treatments to prevent disuse-associated muscle wasting in humans. The above-described effects of disuse appear to be due, at least in part, to a decrease in nitric oxide (NO) bioavailability. Reduced synthesis of NO and/or increased NO destruction (due to increased production of oxygen free radicals) likely contributes to the mitochondrial changes, energetic abnormalities, and muscle atrophy resulting from immobilization. The objective of this study is to investigate the potential benefits of dietary nitrate supplementation on immobilization-induced changes in muscle contractile function and mitochondrial respiratory capacity in young healthy men. Our disuse-induced muscle atrophy model will involve wearing a knee brace for a period of 14 d.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 9, 2025
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 23, 2026
February 1, 2026
11 months
August 8, 2025
February 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle mitochondrial function
Muscle mitochondrial respiratory capacity assessed in vitro using high resolution respirometry and in vivo using a near infrared spectroscopy/occlusion protocol
14 days
Secondary Outcomes (3)
Muscle strength
14 days
Muscle speed
14 days
Muscle power
14 days
Study Arms (2)
Nitrate
EXPERIMENTALNitrate-rich beetroot juice
Placebo
PLACEBO COMPARATORNitrate-free beetroot juice
Interventions
Eligibility Criteria
You may qualify if:
- Men age 18-44
- Above the minimum threshold of the IPAQ questionnaire
- Below the maximum threshold of the IPAQ questionnaire
You may not qualify if:
- Men and women \<18 or \>44 years of age
- Unable to provide informed consent
- Known clotting disorder
- Previous history of deep vein thrombosis
- Injury to either leg resulting in reduced mobility in the previous year
- Currently dieting or weight instability for the past 3 months
- Epileptic
- Pacemaker or other implantable heart device
- Currently taking antibiotics
- Current smoker
- Stage II hypertension (resting blood pressure \>140/\>90)
- Previously undergone a revascularization procedure involving a vascular graft or stenting of the femoral or popliteal arteries
- Those taking phosphodiesterase inhibitors (e.g., Viagra), proton pump inhibitors, antacids, xanthine oxidase inhibitors, hormonal contraceptives or on hormone replacement therapy
- If participant's doctor has ever said that he/she has a heart condition and that he/she should only do physical activity recommended by a doctor
- Pain in chest when doing physical activity
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University Indianapolis
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew R Coggan, PhD
Indiana University Indianapolis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 8, 2025
First Posted
September 9, 2025
Study Start
January 30, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available upon completion of the study and publication of the final results.
All non-PHI individual participant data will be shared upon reasonable request.